GlassScriptPhysician profile
Mark Zuzga
NPI 1740289404
$17,548.85
in general payments reported to CMS, 2019-2025
8 companies · $5,007 in 2025
The $5,007 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,152 · 2020: $27.36 · 2021: $243 · 2022: $1,362 · 2023: $4,837 · 2024: $4,920 · 2025: $5,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,400.00 |
| Food and Beverage | $364.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $15,500.75 | 2022-2025 | Venacure 1470 Pro, Venacure 1470 Pro, Micro Access |
| Silk Road Medical, INC. | $686.14 | 2019 | |
| Medtronic, INC. | $662.84 | 2021-2025 | Turbohawk, Trailblazer, Hawkone |
| Medtronic Vascular, INC. | $468.27 | 2019-2020 | |
| Boston Scientific Corporation | $109.38 | 2019-2025 | Varithena Administration Pack |
| W. L. Gore & Associates, INC. | $70.52 | 2024 | Gore Excluder Aaa Endoprosthesis, Gore Dryseal Flex Introducer Sheath |
| Bard Peripheral Vascular, INC. | $40.15 | 2025 | Venclose Maven Catheter |
| Ekos Corporation | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Zuzga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.